lobbying_filings_raw: ce7df2df-3afc-4bca-9fdc-3f8fae53e812
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json | registrant_state | registrant_country | registrant_house_id | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | affiliated_org_count | client_entity_id | client_government_unit_id | client_match_method | client_match_confidence |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ce7df2df-3afc-4bca-9fdc-3f8fae53e812 | Q2 | 315091 | RUBICON ADVISORS, LLC | 185306 | TEVA PHARMACEUTICALS USA | 2008 | second_quarter | 2008-07-08T19:35:35-04:00 | 90000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/ce7df2df-3afc-4bca-9fdc-3f8fae53e812/", "filing_uuid": "ce7df2df-3afc-4bca-9fdc-3f8fae53e812", "filing_type": "Q2", "filing_type_display": "2nd Quarter - Report", "filing_year": 2008, "filing_period": "second_quarter", "filing_period_display": "2nd Quarter (Apr 1 - June 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/ce7df2df-3afc-4bca-9fdc-3f8fae53e812/print/", "filing_document_content_type": "text/html", "income": "90000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "William Burke, Principal", "dt_posted": "2008-07-08T19:35:35-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "1455 PENNSYLVANIA AVENUE, NW", "registrant_address_2": "SUITE 400", "registrant_different_address": false, "registrant_city": "WASHINGTON", "registrant_state": "DC", "registrant_zip": "20004", "registrant": {"id": 315091, "url": "https://lda.senate.gov/api/v1/registrants/315091/", "house_registrant_id": 39394, "name": "RUBICON ADVISORS, LLC", "description": "Lobbying firm", "address_1": "1455 Pennsylvania Ave Ste 400", "address_2": null, "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20004", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "WILLIAM BURKE", "contact_telephone": "+1 202-652-2290", "dt_updated": "2026-01-18T15:34:19.909863-05:00"}, "client": {"id": 185306, "url": "https://lda.senate.gov/api/v1/clients/185306/", "client_id": 75, "name": "TEVA PHARMACEUTICALS USA", "general_description": "Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA)", "client_government_entity": false, "client_self_select": null, "state": "DC", "state_display": "District of Columbia", "country": "US", "country_display": "United States of America", "ppb_state": null, "ppb_state_display": null, "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2007-02-09"}, "lobbying_activities": [{"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "Healthcare: Pharmaceuticals, Prescription Drug User Fee", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 33519, "prefix": null, "prefix_display": null, "first_name": "WILLIAM", "nickname": null, "middle_name": null, "last_name": "BURKE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 28656, "prefix": null, "prefix_display": null, "first_name": "KATHY", "nickname": null, "middle_name": null, "last_name": "KULKARNI", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": []}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} | DC | US | 39394 | DC | US | US | Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA) | 0 | 0 | 2060118 | normalized_name_dc_fallback | 0.8 |